InvestorsHub Logo
Followers 829
Posts 119625
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Wednesday, 07/11/2018 11:26:59 AM

Wednesday, July 11, 2018 11:26:59 AM

Post# of 867
Keytruda-monotherapy PDUFA in second-line HCC is 11/9/18 (with priority review):

https://www.businesswire.com/news/home/20180711005195/en/FDA-Grants-Priority-Review-Merck%E2%80%99s-Supplemental-Biologics

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRK News